Read more
The Right Price provides an accessible guide to pharmaceutical markets and analytic techniques used to measure the value of drug therapies. It unveils why the pricing of drugs continues to be so challenging and how public and private officials can create more informed policies to achieve the right balance between drug pricing and value.
List of contents
- Acknowledgments
- Preface
- PART 1: THE ECONOMICS OF PRESCRIPTION DRUGS
- Chapter 1: Introduction
- Chapter 2: The prescription drug market
- Chapter 3: Proposed solutions for rising drug prices
- Chapter 4: Measuring the value of prescription drugs
- PART 2: EXPERIENCES MEASURING A DRUG'S VALUE IN THE US AND ABROAD
- Chapter 5: Measuring drug value: Whose job is it anyway?
- Chapter 6: Institute for Clinical and Economic Review (ICER)
- Chapter 7: Other US value assessment frameworks
- Chapter 8: Do drugs for special populations warrant higher prices?
- PART 3: GETTING TO VALUE-BASED PRICING FOR DRUGS
- Chapter 9: Improving value measurement
- Chapter 10: Aligning prices with value
- Chapter 11: The path forward
- Index
About the author
Peter J. Neumann, ScD, is Director of the Center for the Evaluation of Value and Risk in Health (CEVR) at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, and Professor of Medicine at Tufts University School of Medicine. Dr. Neumann is also a member of the editorial advisory board of Health Affairs and the health policy advisory board for the Congressional Budget Office.
Joshua T. Cohen, PhD, is Deputy Director of the Center for the Evaluation of Value and Risk in Health (CEVR) at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, and Research Associate Professor of Medicine at Tufts University School of Medicine.
Daniel A. Ollendorf, PhD, is Director of Value Measurement and Global Health Initiatives at the Center for the Evaluation of Value and Risk in Health (CEVR) at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, and Research Assistant Professor of Medicine at Tufts University School of Medicine. Prior to joining CEVR, he spent ten years as the Chief Scientific Officer at the Institute for Clinical and Economic Review (ICER). Dr. Ollendorf currently serves as a non-resident Fellow at the Center for Global Development, and as Chair of the Health Technology Assessment International (HTAi) Global Policy Forum.
Summary
The Right Price provides an accessible guide to pharmaceutical markets and analytic techniques used to measure the value of drug therapies. It unveils why the pricing of drugs continues to be so challenging and how public and private officials can create more informed policies to achieve the right balance between drug pricing and value.
Additional text
This is a highly readable and timely guide for anyone interested in thoughtful solutions to the nation's ongoing debates about prescription drug pricing, controlling costs, and ensuring affordability while enhancing innovation to improve people's health.
